147 related articles for article (PubMed ID: 11955366)
21. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
22. [Expression of pRb and E2F-1 and telomerase activity in ameloblastoma].
Zhong M; Wang J; Zhang B; Hou L; Yue YL; Li ZJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):406-9. PubMed ID: 15498350
[TBL] [Abstract][Full Text] [Related]
23. Establishment of immortalized ameloblastoma cell line TAM-1.
Tao Q; Huang H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 May; 37(3):167-9. PubMed ID: 12419134
[TBL] [Abstract][Full Text] [Related]
24. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
25. [The study of the invasive biologic behavior of ameloblastoma].
Zhong M; Li ZJ; Wang J; Yue YL; Bao G
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan; 39(1):45-8. PubMed ID: 14989873
[TBL] [Abstract][Full Text] [Related]
26. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma.
Maya R; Sekar B; Murali S
Indian J Dent Res; 2012; 23(1):15-9. PubMed ID: 22842243
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
[TBL] [Abstract][Full Text] [Related]
28. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
30. "Ameloblastoma with mucous cells": review of literature and presentation of 2 cases.
Punnya AV; Rekha K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e20-6. PubMed ID: 19000605
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
32. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders.
Gambichler T; Bischoff S; Bechara FG; Altmeyer P; Kreuter A
J Dermatol Sci; 2008 Feb; 49(2):125-32. PubMed ID: 17826963
[TBL] [Abstract][Full Text] [Related]
33. NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas.
Englund C; Alvord EC; Folkerth RD; Silbergeld D; Born DE; Small R; Hevner RF
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):429-38. PubMed ID: 16008827
[TBL] [Abstract][Full Text] [Related]
34. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase in ameloblastoma].
Zhong M; Han YP; Wang J; Li ZJ; Bao G; Yue YL
Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):427-31. PubMed ID: 14966582
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of cytokeratin 19, involucrin and proliferating cell nuclear antigen (PCNA) in cultured human gingival epithelial sheets.
Murata M; Momose M; Okuda K; Ninagawa Y; Ueda M; Yoshie H
J Int Acad Periodontol; 2005 Oct; 7(4):129-34. PubMed ID: 16245643
[TBL] [Abstract][Full Text] [Related]
36. [Expression of telomerase and p53 in ameloblastoma].
Zhong M; Zhang LH; Wang J; Zhang B; Hou L
Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):127-31. PubMed ID: 14661519
[TBL] [Abstract][Full Text] [Related]
37. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of cytokeratin 19, involucrin and proliferating cell nuclear antigen (PCNA) in cultured human gingival epithelial sheets.
Murata M; Momose M; Okuda K; Ninagawa Y; Ueda M; Hiromasa Y
J Int Acad Periodontol; 2006 Jan; 8(1):33-8. PubMed ID: 16459887
[TBL] [Abstract][Full Text] [Related]
39. An immunohistochemical study of keratin expression in ameloblastoma from a Kenyan population.
Ong'uti MN; Howells GL; Williams DM
Oral Dis; 1999 Apr; 5(2):111-6. PubMed ID: 10522206
[TBL] [Abstract][Full Text] [Related]
40. LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor.
Kitkumthorn N; Mutirangura A
Oral Dis; 2010 Apr; 16(3):286-91. PubMed ID: 20374511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
